National Cancer Institute Home at the National Institutes of Health |

Cancer Prevalence References

Byrne J, Kessler LG, Devesa SS. The prevalence of cancer among adults in the United States: 1987. Cancer 1992; 69(8):2154-2159. [View PDFExternal Web Site Policy]

Capocaccia R, De Angelis R. Estimating the completeness of prevalence based on cancer registry data. Stat Med 1997; 16(4):425-440. [View AbstractExternal Web Site Policy]

Clegg LX, Gail MH, Feuer EJ. Estimating the variance of disease-prevalence estimates from population-based registries. Biometrics 2002; 58(3):684-688. [View AbstractExternal Web Site Policy]

Coldman AJ, McBride ML, Braun T. Calculating the prevalence of cancer. Stat Med 1992;11:1579-89. [View AbstractExternal Web Site Policy]

Connelly RR, Campbell PC, Eisenberg H. Central registry of cancer cases in Connecticut. Public Health Rep 1968;83:386-90. [View PDFExternal Web Site Policy]

De Angelis G, De Angelis R, Frova L, Verdecchia A. MIAMOD: a computer package to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed 1994; 44(2):99-107. [View AbstractExternal Web Site Policy]

De Angelis R, Tavilla A, Verdecchia A, Scoppa S, Hachey M, Feuer EJ et al. Breast cancer survivors in the United States: geographic Variability and Time Trends, 2005-2015. Cancer 2009; 115(9):1954-1966. [View AbstractExternal Web Site Policy]

Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer: estimates based on the Connecticut Tumor Registry. N Engl J Med 1986; 315(22):1394-1397. [View AbstractExternal Web Site Policy]

Gail MH, Kessler L, Midthune D, Scoppa S. Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality. Biometrics 1999; 55(4):1137-1144. [View AbstractExternal Web Site Policy]

Gershman ST, Flannery JT, Barrett H, Nadel RK, Meigs JW. Development of the Connecticut Tumor Registry. Conn Med 1976;40:697-701.

Mariotto A, Capocaccia R, Verdecchia A, Micheli A, Feuer E, Pickle L et al. Projecting SEER cancer survival rates to the US: An ecological regression approach. Cancer Causes Control 2002; 11:101-111. [View AbstractExternal Web Site Policy]

Mariotto A, Warren JL, Knopf KB, Feuer EJ. The prevalence of colorectal cancer patients under care in the US. Cancer 2003;98:1253-61. [Full TextExternal Web Site Policy]

Mariotto AB, Yabroff KR, Feuer EJ, De Angelis R, Brown M. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Cancer Causes Control 2006; 17(10):1215-1226. [View AbstractExternal Web Site Policy]

Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol 2000; 29(2):197-207. [Full TextExternal Web Site Policy]

Simonetti A, Gigli A, Cappcaccia R, Mariotto A. Estimating complete prevalence of cancers diagnosed in childhood. Stat Med 2008; 27(7):990-1007. [View AbstractExternal Web Site Policy]

Verdecchia A, Capocaccia R, Egidi V, Golini A. A method for the estimation of chronic disease morbidity and trends from mortality data. Stat Med 1989; 8(2):201-216. [View AbstractExternal Web Site Policy]

Verdecchia A, De Angelis G, Capocaccia R. Estimation and projections of cancer prevalence from cancer registry data. Stat Med 2002; 21(22):3511-3526. [View AbstractExternal Web Site Policy]

Warren JL, Mariotto AB, Meekins A, Topor M, Brown ML. Current and future utilization of services from medical oncologists. J Clin Oncol 2008; 26(19):3242-3247. [Full TextExternal Web Site Policy]